Hypertriglyceridemia: From Biochemical Aberration to Cardiometabolic Syndrome - Emerging Pathophysiology, Clinical Challenges, and Novel Therapeutics . d [Internet]. 2025 Nov. 15 [cited 2026 Apr. 14];3(2):11-5. Available from: https://www.thediabzen.com/index.php/d/article/view/12